Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN), at a price of $44.50 per share, to 6:00 p.m., New York City time, on April 20, 2012. The tender offer was previously scheduled to expire at 6:00 p.m., […]
Agilent Technologies Inc. (NYSE: A) today introduced a much faster version of the HaloPlex target enrichment system for desktop sequencers. The protocol that previously required approximately 24 hours can now be run in less than six. This enables users to go from sample prep to sequencing in less than a work shift. “Recently we had […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today issued the following statement regarding Roche’s decision to extend for the second time its unsolicited tender offer to acquire all outstanding shares of Illumina for $44.50 […]
A*STAR Institute of Microelectronics (IME), has signed a research collaboration agreement with QuantuMDx Group (QMDx), a UK based biotech company which is developing a range of portable technologies for diagnostics, DNA sequencing and proteomics. Under this collaboration, IME will further advance QMDx’s DNA sequencing nanowire biosensor to the point of commercialization. QMDx is pioneering a […]
SAN DIEGO– Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a second letter to its stockholders outlining Illumina’s unrivaled track record of superior operational performance and financial success. The letter urges stockholders to reject Roche’s efforts to […]
The Ion Proton featured heavily at the Consumer Electronics Show in Las Vegas and the World Economic Forum in Davos. Subject to regulatory approvals beyond research use only, the technology may one day guide patients, particularly those with cancer – to receive treatment most likely to work with their individual genetic profile. The low cost […]
SAN DIEGO — Illumina today announced that Macrogen, Inc., a global sequencing services company based in Korea, purchased an additional ten Illumina HiSeq 2000 systems and two MiSeq systems, as well as HiSeq 2500 upgrades. This strategic scale-up expands Macrogen’s capacity with Illumina’s sequencing systems and will be completed by the end of 2012. “Macrogen’s […]
Shanghai, China, – QIAGEN today announced that it has signed an agreement with Bio-X Center of Shanghai Jiao Tong University to open a joint translational medicine lab in Shanghai. The lab is the first of its kind between QIAGEN and a major research institution in China and is a key milestone in the Company’s expansion […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it filed its definitive proxy statement and sent a letter to shareholders of Illumina, Inc. (NASDAQ: ILMN) urging them to tender their shares into Roche’s offer and vote for Roche’s independent director nominees and other proposals at the 2012 Illumina annual meeting to be held on […]
Redwood City, CA – Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced that the Weill Cornell Medical College has chosen Ingenuity Variant Analysis and Ingenuity iReport for use in its sequencing core facility. Variant Analysis will be used to identify causal variants from the output of whole […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
